Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 This special issue contains several papers on clinical trials, exemplifying Ross Prentice's influence. Preface.

Literature DB >> 24126740

This special issue contains several papers on clinical trials, exemplifying Ross Prentice's influence. Preface.

Jianwen Cai¹, Li Hsu.

Abstract

Mesh：

Substances：
Biomarkers

Year: 2013 PMID： 24126740 DOI： 10.1007/s10985-013-9284-2

Source DB: PubMed Journal: Lifetime Data Anal ISSN： 1380-7870 Impact factor: 1.588

Keyword Cloud
References

× No keyword cloud information.

22 in total

1. Performance of common genetic variants in breast-cancer risk models.

Authors: Sholom Wacholder; Patricia Hartge; Ross Prentice; Montserrat Garcia-Closas; Heather Spencer Feigelson; W Ryan Diver; Michael J Thun; David G Cox; Susan E Hankinson; Peter Kraft; Bernard Rosner; Christine D Berg; Louise A Brinton; Jolanta Lissowska; Mark E Sherman; Rowan Chlebowski; Charles Kooperberg; Rebecca D Jackson; Dennis W Buckman; Peter Hui; Ruth Pfeiffer; Kevin B Jacobs; Gilles D Thomas; Robert N Hoover; Mitchell H Gail; Stephen J Chanock; David J Hunter
Journal: N Engl J Med Date: 2010-03-18 Impact factor: 91.245

2. Evaluating subject-level incremental values of new markers for risk classification rule.

Authors: T Cai; L Tian; D Lloyd-Jones; L J Wei
Journal: Lifetime Data Anal Date: 2013-06-27 Impact factor: 1.588

3. A copula model for marked point processes.

Authors: Liqun Diao; Richard J Cook; Ker-Ai Lee
Journal: Lifetime Data Anal Date: 2013-05-10 Impact factor: 1.588

4. The reasons for geographic and racial differences in stroke study: objectives and design.

Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282

5. Surrogate endpoints in clinical trials: definition and operational criteria.

Authors: R L Prentice
Journal: Stat Med Date: 1989-04 Impact factor: 2.373

6. The analysis of failure times in the presence of competing risks.

Authors: R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal: Biometrics Date: 1978-12 Impact factor: 2.571

7. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors:
Journal: Control Clin Trials Date: 1998-02